Mobile website
The Therapeutic Effects of Chemotherapeutic Drugs through Bronchoartery Perfusion Combined with Immunotherapy on Lung Cancer
- Article
- Figures
- Metrics
- Preview PDF
- Reference
- Related
- Cited by
- Materials
Abstract:
Objective：To evaluate the value of lung cancer treatment by chemotherapeutic drugs through bronchoartery perfusion combined with interferon.Methods：40 cases with lung cancer were randomly divided into 2 groups. 20 cases accepted chemotherapeutic drugs through bronchoartery perfusion combined with interferon were considered as observed group, and the other 20 cases accepted only chemotherapeutic drugs through bronchoartery perfusion as control group. Χ2 test was used to compare the differences of the recent curative effects and survival rates between the two groups. Results：The total effective rate (CR+PR) of the observed group during the first treatment was 60.0% (12/20), which was not significant as compared with that of control group (40.0%) (Χ2= 1.60, P＞0.05). But the survival rates of the observed group during 1 and 2 years were 85.0% (17/20) and 45.0% (9/20), respectively. There were significant differences as compared with 50.0% (10/20) and 10.0% (2/20) in control group (Χ2= 5.58 and 6.14, P＜0.05).Conclusion：Bronchoartery perfusion with chemotherapeutic drugs combined with interferon can raise the survival rates of patients with lung cancer, and is a valuably therapeutic method.
Keywords:
Project Supported:
Clc Number:
